Drug Shortage Report for TEVA-DULOXETINE
Report ID | 126936 |
Drug Identification Number | 02456761 |
Brand name | TEVA-DULOXETINE |
Common or Proper name | DULOXETINE HCL 60MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DULOXETINE |
Strength(s) | 60MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-21 |
Estimated end date | 2021-02-28 |
Actual end date | 2021-01-27 |
Shortage status | Resolved |
Updated date | 2021-01-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-01-28 | French | Compare |
v7 | 2021-01-28 | English | Compare |
v6 | 2021-01-14 | French | Compare |
v5 | 2021-01-14 | English | Compare |
v4 | 2021-01-07 | French | Compare |
v3 | 2021-01-07 | English | Compare |
v2 | 2020-10-22 | French | Compare |
v1 | 2020-10-22 | English | Compare |
Showing 1 to 8 of 8